UCB, a global biopharmaceutical company, today announced the start of BE BOLD, a head-to-head Phase 3b study, comparing BIMZELX® (bimekizumab-bkzx), an interleukin (IL)-17A and IL-17F inhibitor, with ...
Arthrosis refers to a specific type of arthritis known as osteoarthritis (OA), while arthritis refers to a large group of conditions characterized by joint pain ... joints on both sides of the body) ...
The good news in the current study, the researchers say, is that reducing your waistline may help alleviate a range of chronic pain issues, instead of the need for medication to target the pain sites.